Low birth weight is associated with earlier onset of end-stage renal disease in Danish patients with autosomal dominant polycystic kidney disease
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Low birth weight is associated with earlier onset of end-stage renal disease in Danish patients with autosomal dominant polycystic kidney disease. / Orskov, Bjarne; Christensen, Karl Bang; Feldt-Rasmussen, Bo; Strandgaard, Svend.
I: Kidney International, Bind 81, Nr. 9, 05.2012, s. 919-24.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Low birth weight is associated with earlier onset of end-stage renal disease in Danish patients with autosomal dominant polycystic kidney disease
AU - Orskov, Bjarne
AU - Christensen, Karl Bang
AU - Feldt-Rasmussen, Bo
AU - Strandgaard, Svend
PY - 2012/5
Y1 - 2012/5
N2 - Low-birth-weight individuals have a higher risk of hypertension and end-stage renal disease (ESRD). Here we investigated whether low birth weight was associated with earlier onset of ESRD in patients with autosomal dominant polycystic kidney disease (ADPKD). In collaboration with all Danish departments of nephrology, 307 of 357 patients with ADPKD and ESRD born and living in Denmark were recruited. We were able to analyze complete data of 284 patients obtained from both hospital medical files and midwife protocols in the Danish State Archives. Multivariable linear regression adjusted for birth weight, adult height, mean arterial pressure, gender, birth decade, and type of antihypertensive treatment showed that for every kilogram increase in birth weight, the age at onset of ESRD significantly increased by 1.7 years. Male gender and increased mean arterial pressure were both associated with earlier onset of ESRD. Patients treated with renin-angiotensin system blockade or calcium channel blockers during follow-up had significantly later onset of ESRD by 4.3 years and 2.1 years, respectively. Treatment with beta-blockade or a diuretic was not associated with the age at onset of ESRD. Thus, low birth weight may contribute to considerable phenotypic variability in the progression of renal disease between individuals with ADPKD.
AB - Low-birth-weight individuals have a higher risk of hypertension and end-stage renal disease (ESRD). Here we investigated whether low birth weight was associated with earlier onset of ESRD in patients with autosomal dominant polycystic kidney disease (ADPKD). In collaboration with all Danish departments of nephrology, 307 of 357 patients with ADPKD and ESRD born and living in Denmark were recruited. We were able to analyze complete data of 284 patients obtained from both hospital medical files and midwife protocols in the Danish State Archives. Multivariable linear regression adjusted for birth weight, adult height, mean arterial pressure, gender, birth decade, and type of antihypertensive treatment showed that for every kilogram increase in birth weight, the age at onset of ESRD significantly increased by 1.7 years. Male gender and increased mean arterial pressure were both associated with earlier onset of ESRD. Patients treated with renin-angiotensin system blockade or calcium channel blockers during follow-up had significantly later onset of ESRD by 4.3 years and 2.1 years, respectively. Treatment with beta-blockade or a diuretic was not associated with the age at onset of ESRD. Thus, low birth weight may contribute to considerable phenotypic variability in the progression of renal disease between individuals with ADPKD.
KW - Adult
KW - Age of Onset
KW - Antihypertensive Agents
KW - Chi-Square Distribution
KW - Cross-Sectional Studies
KW - Denmark
KW - Disease Progression
KW - Female
KW - Genetic Predisposition to Disease
KW - Humans
KW - Hypertension
KW - Infant, Low Birth Weight
KW - Infant, Newborn
KW - Kidney Failure, Chronic
KW - Linear Models
KW - Male
KW - Middle Aged
KW - Multivariate Analysis
KW - Phenotype
KW - Polycystic Kidney, Autosomal Dominant
KW - Retrospective Studies
KW - Risk Assessment
KW - Risk Factors
KW - Time Factors
U2 - 10.1038/ki.2011.459
DO - 10.1038/ki.2011.459
M3 - Journal article
C2 - 22297678
VL - 81
SP - 919
EP - 924
JO - Kidney International
JF - Kidney International
SN - 0085-2538
IS - 9
ER -
ID: 48914882